Ojaara

In pleasant surprise for GSK, FDA approves Jakafi challenger Ojjaara in broad blood cancer use
Fierce Pharma
Sun, 09/17/23 - 09:47 pm
GSK
FDA
Ojaara
momelotinib
myelofibrosis